ProCyte other research news

PRCY (Kirkland, Wash.) announced animal data showing that the agent prevented chemotherapy-induced hair loss after a single dose injected into the skin. The study, which will be submitted for publication, rated the presence of a tuft of hair on otherwise bald rats.

A dose response was seen, the company told BioCentury. Other work by PRCY has shown that its peptide-copper compounds increase the production of collagen and proteoglycan, components of the extracellular matrix. ...